Drug profile · INN
armodafinil
NUVIGIL
armodafinil (NUVIGIL) is a dopamine transporter inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — armodafinil
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 17
- Data quality
- 0.89
Quick answer
armodafinil (NUVIGIL) is a dopamine transporter inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine transporter inhibitor
Primary target: Sodium-dependent dopamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is armodafinil?
armodafinil (NUVIGIL) is a dopamine transporter inhibitor. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for armodafinil?
NUVIGIL is a marketed brand name for armodafinil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of armodafinil?
armodafinil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.